BlackRock Health Science Term Trust (BMEZ) said Friday it launched a tender offer to acquire up to 40% of outstanding common shares.
Shares will be repurchased at a price equal to 99.5% of the fund's net asset value per share.
If more than 40% of the fund's shares are tendered, it will acquire them from tendering shareholders on a pro-rata basis.
The tender offer expires on April 17, and the pricing date is set for April 21.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.